| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.949 | 0.004 | 0.957 | Apoptosis agonist | 0.957 0.004 CHEMBL517341 0.948 0.004 CHEMBL3526207 | CHEMBL517341 | |
| 0.861 | 0.004 | 0.922 | Cardiotonic | 0.922 0.003 CHEMBL517341 0.843 0.004 CHEMBL3526207 | CHEMBL517341 | |
| 0.849 | 0.01 | 0.89 | Transcription factor NF kappa B inhibitor | 0.89 0.007 CHEMBL517341 0.876 0.008 CHEMBL3526207 | CHEMBL517341 | |
| 0.827 | 0.012 | 0.827 | Antiinflammatory | 0.785 0.017 CHEMBL517341 0.825 0.012 CHEMBL3526207 | ||
| 0.67 | 0.003 | 0.7 | Transcription factor STAT inhibitor | 0.7 0.003 CHEMBL517341 0.655 0.004 CHEMBL3526207 | CHEMBL517341 | |
| 0.67 | 0.004 | 0.72 | Diuretic | 0.72 0.004 CHEMBL517341 0.622 0.004 CHEMBL3526207 | CHEMBL517341 | |
| 0.67 | 0.005 | 0.753 | Hypoxia-inducible factor 1 alpha inhibitor | 0.753 0.004 CHEMBL517341 0.673 0.005 CHEMBL3526207 | CHEMBL517341 | |
| 0.66 | 0.007 | 0.705 | Nitric oxide antagonist | 0.634 0.008 CHEMBL517341 0.705 0.005 CHEMBL3526207 | CHEMBL3526207 | |
| 0.654 | 0.003 | 0.691 | Transcription factor STAT3 inhibitor | 0.691 0.002 CHEMBL517341 0.643 0.003 CHEMBL3526207 | CHEMBL517341 | |
| 0.593 | 0 | 0.671 | Na+ K+ transporting ATPase inhibitor | 0.671 0 CHEMBL517341 0.619 0 CHEMBL3526207 | CHEMBL517341 | |
| 0.568 | 0.004 | 0.568 | Interleukin 6 antagonist | 0.51 0.004 CHEMBL517341 0.502 0.005 CHEMBL3526207 | ||
| 0.582 | 0.021 | 0.582 | Cholesterol antagonist | 0.346 0.066 CHEMBL517341 0.339 0.069 CHEMBL3526207 | ||
| 0.564 | 0.018 | 0.613 | Immunosuppressant | 0.547 0.021 CHEMBL517341 0.613 0.012 CHEMBL3526207 | CHEMBL3526207 | |
| 0.5 | 0.004 | 0.5 | Lipocortins synthesis antagonist | 0.441 0.006 CHEMBL517341 0.498 0.004 CHEMBL3526207 | ||
| 0.491 | 0.007 | 0.491 | Hepatoprotectant | 0.39 0.014 CHEMBL517341 0.457 0.009 CHEMBL3526207 | ||
| 0.469 | 0.005 | 0.469 | Sodium/bile acid cotransporter inhibitor | 0.37 0.028 CHEMBL517341 0.455 0.007 CHEMBL3526207 | ||
| 0.502 | 0.04 | 0.524 | Antibacterial | 0.458 0.054 CHEMBL517341 0.524 0.034 CHEMBL3526207 | CHEMBL3526207 | |
| 0.464 | 0.004 | 0.464 | Aromatase inhibitor | 0.217 0.008 CHEMBL517341 0.329 0.005 CHEMBL3526207 | ||
| 0.451 | 0.003 | 0.451 | Mineralocorticoid receptor antagonist | 0.356 0.003 CHEMBL517341 0.432 0.003 CHEMBL3526207 | ||
| 0.493 | 0.063 | 0.493 | Caspase 9 stimulant | 0.274 0.224 CHEMBL517341 0.327 0.166 CHEMBL3526207 | ||
| 0.427 | 0.013 | 0.487 | P-glycoprotein inhibitor | 0.487 0.009 CHEMBL517341 0.454 0.011 CHEMBL3526207 | CHEMBL517341 | |
| 0.428 | 0.03 | 0.436 | Antioxidant | 0.367 0.042 CHEMBL517341 0.436 0.029 CHEMBL3526207 | CHEMBL3526207 | |
| 0.398 | 0.006 | 0.398 | DNA polymerase I inhibitor | 0.314 0.01 CHEMBL517341 0.349 0.008 CHEMBL3526207 | ||
| 0.399 | 0.039 | 0.425 | Apoptosis antagonist | 0.294 0.09 CHEMBL517341 0.425 0.032 CHEMBL3526207 | CHEMBL3526207 | |
| 0.332 | 0.008 | 0.332 | Cholesterol synthesis inhibitor | 0.163 0.038 CHEMBL517341 0.266 0.016 CHEMBL3526207 | ||
| 0.322 | 0.003 | 0.322 | Androgen agonist | 0.142 0.008 CHEMBL517341 0.227 0.004 CHEMBL3526207 | ||
| 0.348 | 0.036 | 0.351 | Hypolipemic | 0.204 0.091 CHEMBL517341 0.351 0.035 CHEMBL3526207 | CHEMBL3526207 | |
| 0.352 | 0.058 | 0.352 | Caspase 3 stimulant | 0.287 0.085 CHEMBL517341 0.302 0.078 CHEMBL3526207 | ||
| 0.307 | 0.016 | 0.307 | Neurotrophic factor enhancer | 0.17 0.11 CHEMBL517341 0.228 0.053 CHEMBL3526207 | ||
| 0.282 | 0.008 | 0.282 | Androgen antagonist | 0.177 0.016 CHEMBL517341 0.213 0.012 CHEMBL3526207 | ||
| 0.26 | 0.004 | 0.26 | Arachidonic acid antagonist | 0.221 0.016 CHEMBL517341 0.243 0.007 CHEMBL3526207 | ||
| 0.259 | 0.006 | 0.272 | Microtubule formation inhibitor | 0.251 0.009 CHEMBL517341 0.272 0.004 CHEMBL3526207 | CHEMBL3526207 | |
| 0.298 | 0.054 | 0.298 | Tumour necrosis factor alpha release inhibitor | 0.245 0.077 CHEMBL3526207 | ||
| 0.279 | 0.039 | 0.279 | Anesthetic general | 0.164 0.1 CHEMBL3526207 | ||
| 0.252 | 0.028 | 0.252 | Interferon gamma antagonist | 0.188 0.046 CHEMBL517341 0.195 0.043 CHEMBL3526207 | ||
| 0.273 | 0.054 | 0.273 | Interleukin antagonist | 0.251 0.061 CHEMBL517341 0.235 0.067 CHEMBL3526207 | ||
| 0.197 | 0.004 | 0.197 | Anabolic | 0.169 0.01 CHEMBL517341 0.191 0.005 CHEMBL3526207 | ||
| 0.277 | 0.086 | 0.277 | Immunostimulant | 0.2 0.12 CHEMBL517341 0.243 0.099 CHEMBL3526207 | ||
| 0.209 | 0.02 | 0.225 | Antineoplastic antibiotic | 0.216 0.018 CHEMBL517341 0.225 0.017 CHEMBL3526207 | CHEMBL3526207 | |
| 0.217 | 0.035 | 0.217 | Melanin inhibitor | 0.19 0.045 CHEMBL517341 0.169 0.06 CHEMBL3526207 | ||
| 0.202 | 0.021 | 0.279 | Farnesoid X receptor antagonist | 0.279 0.008 CHEMBL3526207 | CHEMBL3526207 | |
| 0.242 | 0.074 | 0.242 | Angiogenesis stimulant | 0.188 0.101 CHEMBL517341 0.213 0.088 CHEMBL3526207 | ||
| 0.24 | 0.074 | 0.24 | DNA synthesis inhibitor | 0.197 0.128 CHEMBL517341 0.186 0.144 CHEMBL3526207 | ||
| 0.183 | 0.019 | 0.188 | Antineoplastic alkaloid | 0.188 0.017 CHEMBL517341 0.15 0.028 CHEMBL3526207 | CHEMBL517341 | |
| 0.173 | 0.013 | 0.173 | ABCA1 expression enhancer | 0.143 0.019 CHEMBL517341 0.154 0.016 CHEMBL3526207 | ||
| 0.261 | 0.107 | 0.261 | Interleukin 2 agonist | 0.244 0.126 CHEMBL517341 0.224 0.151 CHEMBL3526207 | ||
| 0.17 | 0.026 | 0.17 | Pregnane X receptor agonist | 0.153 0.047 CHEMBL517341 0.143 0.067 CHEMBL3526207 | ||
| 0.185 | 0.047 | 0.185 | Protein kinase stimulant | 0.167 0.057 CHEMBL517341 0.121 0.091 CHEMBL3526207 | ||
| 0.135 | 0.009 | 0.135 | Glycine receptor agonist | 0.133 0.009 CHEMBL517341 0.101 0.02 CHEMBL3526207 | ||
| 0.13 | 0.005 | 0.13 | RNA-directed RNA polymerase stimulant | 0.07 0.009 CHEMBL517341 0.127 0.005 CHEMBL3526207 | ||
| 0.213 | 0.088 | 0.213 | Free radical scavenger | 0.176 0.118 CHEMBL517341 0.193 0.103 CHEMBL3526207 | ||
| 0.135 | 0.011 | 0.135 | Glycine receptor antagonist | 0.083 0.053 CHEMBL517341 0.091 0.041 CHEMBL3526207 | ||
| 0.146 | 0.023 | 0.171 | Toll-Like receptor 4 antagonist | 0.171 0.012 CHEMBL517341 0.135 0.031 CHEMBL3526207 | CHEMBL517341 | |
| 0.146 | 0.025 | 0.146 | Hedgehog signaling inhibitor | 0.117 0.043 CHEMBL517341 0.104 0.058 CHEMBL3526207 | ||
| 0.177 | 0.064 | 0.177 | Phospholipase C inhibitor | 0.17 0.072 CHEMBL3526207 | ||
| 0.115 | 0.003 | 0.115 | Progesterone agonist | 0.092 0.004 CHEMBL517341 0.101 0.003 CHEMBL3526207 | ||
| 0.117 | 0.008 | 0.129 | Progesterone antagonist | 0.059 0.015 CHEMBL517341 0.129 0.007 CHEMBL3526207 | CHEMBL3526207 | |
| 0.158 | 0.05 | 0.158 | Adenylate cyclase stimulant | 0.132 0.096 CHEMBL517341 0.138 0.085 CHEMBL3526207 | ||
| 0.152 | 0.045 | 0.152 | Protein-tyrosine phosphatase 1B inhibitor | 0.11 0.07 CHEMBL517341 0.104 0.074 CHEMBL3526207 | ||
| 0.136 | 0.031 | 0.145 | Estrogen antagonist | 0.141 0.028 CHEMBL517341 0.145 0.025 CHEMBL3526207 | CHEMBL3526207 | |
| 0.183 | 0.08 | 0.208 | Platelet adhesion inhibitor | 0.208 0.067 CHEMBL3526207 | CHEMBL3526207 | |
| 0.166 | 0.065 | 0.166 | Protein-tyrosine phosphatase inhibitor | 0.126 0.107 CHEMBL517341 0.122 0.112 CHEMBL3526207 | ||
| 0.236 | 0.138 | 0.236 | Antithrombotic | |||
| 0.111 | 0.015 | 0.202 | Estrogen agonist | 0.202 0.008 CHEMBL517341 0.133 0.013 CHEMBL3526207 | CHEMBL517341 | |
| 0.205 | 0.111 | 0.205 | DNA damaging | |||
| 0.098 | 0.006 | 0.098 | Lipocortins synthesis agonist | 0.088 0.009 CHEMBL517341 0.096 0.006 CHEMBL3526207 | ||
| 0.1 | 0.008 | 0.1 | Potassium channel Kv1.3 blocker | 0.094 0.009 CHEMBL517341 0.057 0.023 CHEMBL3526207 | ||
| 0.096 | 0.009 | 0.096 | Aldosterone antagonist | 0.057 0.022 CHEMBL517341 0.073 0.013 CHEMBL3526207 | ||
| 0.091 | 0.007 | 0.091 | Acetyl-CoA transferase 2 inhibitor | 0.063 0.026 CHEMBL517341 0.075 0.014 CHEMBL3526207 | ||
| 0.149 | 0.069 | 0.149 | Lipid peroxidase inhibitor | 0.136 0.079 CHEMBL3526207 | ||
| 0.089 | 0.011 | 0.089 | 5-Alpha-reductase inhibitor | 0.063 0.015 CHEMBL3526207 | ||
| 0.142 | 0.065 | 0.142 | Ca2+-transporting ATPase inhibitor | 0.142 0.065 CHEMBL517341 0.138 0.081 CHEMBL3526207 | ||
| 0.114 | 0.04 | 0.117 | Estrogen receptor beta antagonist | 0.111 0.045 CHEMBL517341 0.117 0.036 CHEMBL3526207 | CHEMBL3526207 | |
| 0.075 | 0.004 | 0.075 | Glucose-6-phosphate dehydrogenase inhibitor | 0.044 0.017 CHEMBL517341 0.06 0.007 CHEMBL3526207 | ||
| 0.073 | 0.005 | 0.093 | Microtubule stabilization | 0.093 0.004 CHEMBL517341 0.09 0.004 CHEMBL3526207 | CHEMBL517341 | |
| 0.194 | 0.127 | 0.194 | Interleukin agonist | |||
| 0.071 | 0.005 | 0.071 | Steroid 17-alpha-hydroxylase/17,20 lyase inhibitor | 0.033 0.009 CHEMBL517341 | ||
| 0.067 | 0.009 | 0.067 | Glucocorticoid antagonist | 0.048 0.015 CHEMBL517341 0.066 0.009 CHEMBL3526207 | ||
| 0.072 | 0.014 | 0.148 | Opioid kappa receptor agonist | 0.148 0.006 CHEMBL517341 0.044 0.029 CHEMBL3526207 | CHEMBL517341 | |
| 0.165 | 0.108 | 0.398 | Antimitotic | 0.398 0.023 CHEMBL517341 0.361 0.03 CHEMBL3526207 | CHEMBL517341 | |
| 0.143 | 0.093 | 0.174 | Growth hormone agonist | 0.174 0.071 CHEMBL517341 0.173 0.071 CHEMBL3526207 | CHEMBL517341 | |
| 0.084 | 0.039 | 0.084 | CDC25A inhibitor | 0.072 0.054 CHEMBL3526207 | ||
| 0.252 | 0.21 | 0.252 | Cyclophilin D inhibitor | |||
| 0.066 | 0.026 | 0.068 | Protein 50S ribosomal subunit inhibitor | 0.063 0.029 CHEMBL517341 0.068 0.025 CHEMBL3526207 | CHEMBL3526207 | |
| 0.044 | 0.011 | 0.045 | Tubulin agonist | 0.045 0.01 CHEMBL517341 0.045 0.011 CHEMBL3526207 | CHEMBL3526207 | |
| 0.101 | 0.068 | 0.101 | Expectorant | |||
| 0.089 | 0.058 | 0.089 | ATPase (Vacuolar H+) inhibitor | 0.082 0.072 CHEMBL517341 0.08 0.079 CHEMBL3526207 | ||
| 0.087 | 0.056 | 0.092 | Transcription factor NF kappa B stimulant | 0.092 0.048 CHEMBL517341 0.082 0.066 CHEMBL3526207 | CHEMBL517341 | |
| 0.041 | 0.013 | 0.041 | HMG CoA reductase inhibitor | 0.035 0.023 CHEMBL517341 0.041 0.014 CHEMBL3526207 | ||
| 0.051 | 0.024 | 0.051 | Estradiol 17 beta-dehydrogenase inhibitor | |||
| 0.043 | 0.019 | 0.105 | Estrogen receptor alpha agonist | 0.105 0.008 CHEMBL517341 0.062 0.015 CHEMBL3526207 | CHEMBL517341 | |
| 0.103 | 0.08 | 0.135 | Interleukin 2 antagonist | 0.135 0.028 CHEMBL517341 | CHEMBL517341 | |
| 0.091 | 0.07 | 0.091 | Bile acid receptor antagonist | |||
| 0.063 | 0.043 | 0.065 | Nitric oxide donor | 0.065 0.04 CHEMBL3526207 | CHEMBL3526207 | |
| 0.124 | 0.107 | 0.137 | NOS3 expression enhancer | 0.137 0.087 CHEMBL3526207 | CHEMBL3526207 | |
| 0.025 | 0.011 | 0.025 | Corticosteroid-like | 0.022 0.014 CHEMBL517341 0.023 0.013 CHEMBL3526207 | ||
| 0.06 | 0.047 | 0.06 | Heme oxygenase stimulant | 0.057 0.054 CHEMBL517341 0.058 0.051 CHEMBL3526207 | ||
| 0.018 | 0.009 | 0.018 | Vitamin D receptor agonist | 0.015 0.014 CHEMBL3526207 | ||
| 0.058 | 0.05 | 0.064 | Transcription factor AP-1 inhibitor | 0.064 0.038 CHEMBL3526207 | CHEMBL3526207 | |
| 0.101 | 0.095 | 0.206 | Amylase inhibitor | 0.206 0.042 CHEMBL3526207 | CHEMBL3526207 | |
| 0.029 | 0.024 | 0.068 | Estrogen receptor beta agonist | 0.068 0.016 CHEMBL517341 0.051 0.019 CHEMBL3526207 | CHEMBL517341 | |
| 0.028 | 0.027 | 0.028 | Estradiol 17 beta-dehydrogenase 3 inhibitor | |||
| 0.019 | 0.019 | 0.02 | Estrone sulfatase inhibitor | 0.02 0.017 CHEMBL517341 | CHEMBL517341 | |
| 0.042 | 0.042 | 0.06 | Parathyroid hormone antagonist | 0.06 0.011 CHEMBL3526207 | CHEMBL3526207 | |
| 0.019 | 0.024 | 0.024 | Vitamin D receptor antagonist | 0.024 0.012 CHEMBL3526207 | CHEMBL3526207 | |
| 0.13 | 0.141 | 0.189 | ATPase inhibitor | 0.189 0.047 CHEMBL517341 | CHEMBL517341 | |
| 0.083 | 0.129 | 0.114 | Bone formation stimulant | 0.114 0.091 CHEMBL3526207 | CHEMBL3526207 | |
| 0.149 | 0.195 | 0.177 | Peptidyltransferase inhibitor | 0.177 0.134 CHEMBL3526207 | CHEMBL3526207 | |
| 0.047 | 0.157 | 0.078 | Opioid kappa receptor antagonist | 0.078 0.061 CHEMBL517341 | CHEMBL517341 | |
| 0.042 | 0.299 | 0.12 | Adenylate cyclase inhibitor | 0.12 0.067 CHEMBL517341 | CHEMBL517341 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |